Top Markets
Coin of the day
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Rankning i aktier #99999
Acticor Biotech SAS operates as a clinical stage biotechnology company that... Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.
Aktiekurs
$0.28545656
Marknadsvärde
$4.50M
Förändring (1 dag)
5.97%
Förändring (1 år)
0.00%
Land
FR
Handel Acticor Biotech SAS (ALACT)

Kategori

Aktiekurshistorik för Acticor Biotech SAS (ALACT)
Högsta slutkurs: $0.29 den 2024-12-01

Lägsta slutkurs: $7.56 den 2021-11-01
Aktiekurshistorik för Acticor Biotech SAS från 2021 till 2026
Årlig aktiekursutveckling
År Prestanda
2024 -90.82%
2023 -58.62%
2022 31.92%
2021 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$36.74 -53.49%
DK
$451.49 -11.91%
US
$737.00 9.61%
US
$297.72 51.37%
BE
$94.95 -40.77%
AU